Predictive probability early termination plans for phase II clinical trials
- PMID: 526523
Predictive probability early termination plans for phase II clinical trials
Abstract
A phase II clinical trial is designed to gather data to help decide whether an experimental treatment has sufficient effectiveness to justify further study. In a one-arm trial with dichotomous outcome, we wish to test a simple null hypothesis on the Bernoulli parameter against a one-sided alternative in a sample of N patients. It is advisable to have a rule to terminate the trial early when evidence accumulates that the treatment is ineffective. Predictive probabilities based on the binomial distribution and beta and uniform prior distributions for the binomial parameter are found to be useful as the basis of group sequential designs. Size, power and average sample size for these designs are discussed. A process for the specification of an early termination plan, advice on the quantification of prior beliefs, and illustrative examples are included.
Similar articles
-
[How to assess the size of a clinical trial?].Rev Mal Respir. 1994;11(6):547-57. Rev Mal Respir. 1994. PMID: 7831504 Review. French.
-
How large should a phase II trial of a new drug be?Cancer Treat Rep. 1987 Nov;71(11):1079-85. Cancer Treat Rep. 1987. PMID: 3315196 Review.
-
On Simon's two-stage design for single-arm phase IIA cancer clinical trials under beta-binomial distribution.Stat Med. 2010 May 10;29(10):1084-95. doi: 10.1002/sim.3805. Stat Med. 2010. PMID: 20077506
-
Early stopping for sequential restricted tests of binomial distributions.Biometrics. 1983 Sep;39(3):695-710. Biometrics. 1983. PMID: 6652203
-
Stochastically curtailed phase II clinical trials.Stat Med. 2007 Mar 30;26(7):1462-72. doi: 10.1002/sim.2653. Stat Med. 2007. PMID: 16900560
Cited by
-
Interpreting a Bayesian phase II futility clinical trial.Trials. 2022 Nov 22;23(1):953. doi: 10.1186/s13063-022-06877-7. Trials. 2022. PMID: 36414953 Free PMC article. Clinical Trial.
-
A predictive probability design for phase II cancer clinical trials.Clin Trials. 2008;5(2):93-106. doi: 10.1177/1740774508089279. Clin Trials. 2008. PMID: 18375647 Free PMC article.
-
Applications of the prediction of satisfaction design for monitoring single-arm phase II trials.PLoS One. 2024 Sep 26;19(9):e0305814. doi: 10.1371/journal.pone.0305814. eCollection 2024. PLoS One. 2024. PMID: 39325832 Free PMC article.
-
The utility of Bayesian predictive probabilities for interim monitoring of clinical trials.Clin Trials. 2014 Aug;11(4):485-493. doi: 10.1177/1740774514531352. Epub 2014 May 28. Clin Trials. 2014. PMID: 24872363 Free PMC article.
-
Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma.Stat Methods Med Res. 2018 May;27(5):1451-1463. doi: 10.1177/0962280216662070. Epub 2016 Sep 1. Stat Methods Med Res. 2018. PMID: 27587590 Free PMC article.